Add to My Stocks
$4.5 $0.05 (1.1%) MLNT stock closing price Sep 21, 2018 (Closing)

The MELINTA THERAPT cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the MELINTA THERAPT debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as MELINTA THERAPT revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. MELINTA THERAPT cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. MELINTA THERAPT had cash and cash equivalents of $11.4M at the beginning of the year and $128.58M at year end for 2017. MELINTA THERAPT had an outflow of $-75.59M from operating activities, $37.71M inflow due to financing activities, and $155.06M inflow due to investing activities for 2017.

View details of MELINTA THERAPT cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012201120102009
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities-1.35M16.43M-3.24M8.72M8.47M-0.86M1.99M--0.77M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net-15.78M14.32M6.04M2.98M3.42M1.58M-1.66M2.05M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.84M-0.01M-0.04M-0.05M-0.13M-0.01M-0.01M-0.16M-0.02M
Acquisition Disposition of Subsidiaires161.41M--------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-5.5M--------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-169.6M142.08M48.88M54.46M78.32M-20.5M25.5M
Issuance (Repayment) of Debt Securities38.86M-4.44M1M3M5M-15M--
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-1.24M-0.28M-0.54M-0.13M-0.5M-0.7M-1.18M-0.01M-0.25M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year11.4M153.76M99.11M96.5M70.1M15.6M20.04M17.26M9.35M
Cash & Equivalents at Year End128.58M231.55M153.76M99.11M96.5M70.1M15.6M20.04M17.26M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The MELINTA THERAPT stock price history and MELINTA THERAPT stock comparison chart inevitably reflect its cash flow situation.

  • MELINTA THERAPT saw a positive change in Net Change in Cash and Cash Equivalents of $117.17M in 2017. Apart from the MELINTA THERAPT stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: MELINTA THERAPT reported a negative operating cash flow of $-75.59M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a positive value of $155.06M for MLNT stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. MELINTA THERAPT earned $37.71M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For MELINTA THERAPT Cash Flow